CN1301120C - Medicine for treating breadth gasp, cough, asthma and phelgm - Google Patents
Medicine for treating breadth gasp, cough, asthma and phelgm Download PDFInfo
- Publication number
- CN1301120C CN1301120C CNB2005100349969A CN200510034996A CN1301120C CN 1301120 C CN1301120 C CN 1301120C CN B2005100349969 A CNB2005100349969 A CN B2005100349969A CN 200510034996 A CN200510034996 A CN 200510034996A CN 1301120 C CN1301120 C CN 1301120C
- Authority
- CN
- China
- Prior art keywords
- medicine
- cough
- asthma
- present
- phlegm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine for treating polypnea, cough and stethocatharsis. The present invention is proportionally prepared from the raw material of honey-fried herba ephedrae, earth worm, northern apricot kernel, heartleaf houttuynia herb, platycodon root, xanthium, clam meal, licorice root, magnoliae and common coltsfoot flower according to the different characteristics of each traditional Chinese medicine. The medicine of the present invention is used for treating polypnea, cough and stethocatharsis in clinics, and has the efficacy of qi promotion, asthma relief, cough stop, phlegm elimination, inflammation relief, antianaphylaxis and detoxification.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of tachypnea, cough with asthma, coughing up phlegm, being specifically related to a kind of is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Background technology
Tachypnea pants, cough that to cough up phlegm be the most important primary symptom of respiratory system disease, nearly all respiratory illness all can take place, and is characteristics with these symptoms all clinically as acute and chronic bronchitis, chronic obstructive disease of lung (COPD), bronchial asthma, pulmonary infection etc.According to epidemiology statistics, China's chronic bronchitis sickness rate is 6-8%, and asthma prevalence is 0.5-5%, and the COPD sickness rate is 3.17%, and the U.S. children asthma prevalence is 25.5%, and the adult is 9.9%, and the whole world has 500,000,000 people to suffer from this group disease approximately.The serious illness is not only endangering thousands of patients' physical and mental health, and has brought great mental burden and economic loss to family.The means of the above disease of western medical treatment adopt methods such as anti-inflammation, spasmolytic Zhichuan, antiinflammatory antiallergic, relieving cough and resolving phlegm usually at present.Though the kind of medicine is many, and wherein majority is not that Sino-foreign joint venture is exactly the medicine of foreign import, and clinical application is constantly upgraded, and the expensive high of expenses for medicine price makes a lot of people be difficult to really bear, and medical care insurance also is difficult to accept, and is mostly that the smelting mark does not effect a permanent cure." effect a permanent cure " as for antiinflammatory, have only the use 17-hydroxy-11-dehydrocorticosterone substantially.These drug use long periods will produce a large amount of effects of paying, and influence quality of life, even influence the state of an illness.Therefore utilize the resource medicine of motherland, develop new conclusive, the remarkable and nontoxic pair effect of curative effect, not only pleasantly relieving asthma, the medicine of relieving cough and resolving phlegm but also antiinflammatory antiallergic one has great clinical value and social value.
Summary of the invention
The object of the present invention is to provide a kind of medicine for the treatment of tachypnea, cough with asthma, coughing up phlegm, this medicine have pleasantly relieving asthma, the effect of cough-relieving expectoration, antiinflammatory antiallergic and detoxifcation.
Solution of the present invention is based on understanding and the Therapeutic Principle of motherland's medical science to " cough " and " the syndrome of dyspnea " mechanism, at first use the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs of the traditional Chinese medical science, from motherland's medicine treasure-house, pick out and have pleasant relievining asthma, the cough-relieving expectoration, the classical Chinese medicine of effect such as antiinflammatory antiallergic detoxifcation, and with reference to the research of modern Chinese medicine pharmacology, understand the contained effective chemical analysis of wherein every flavor Chinese medicine in depth, confirming that contained effective chemical analysis is that the Chinese medicine screening of supporting itself herbal medicine efficacy to learn comes out, further work out the most rational recipe ingredient, and repeatedly practise clinical, improve, reaching optimal clinical efficacy is optimum formula.
The effective ingredient of medicine of the present invention is made by following component: (consumption is a weight portion):
Herba Ephedrae (processed) 3～13 Pheretimas 8～26 Semen Armeniacae Amarums 2～15 Herba Houttuyniae 5～30 Radix Platycodoniss 2～20
Fructus Xanthii 1～10 Pulvis concha Mactrae 3～20 Radix Glycyrrhizaes 1～20 Flos Magnoliae 4～18 Flos Farfaraees 3～18.
Preferred weight (part) ratio range of the component of preparation medicine of the present invention is:
Herba Ephedrae (processed) 4～8 Pheretimas 10～24 Semen Armeniacae Amarums 6～10 Herba Houttuyniae 6～20 Radix Platycodoniss 10～15
Fructus Xanthii 4～8 Pulvis concha Mactrae 8～15 Radix Glycyrrhizaes 2～10 Flos Magnoliae 5～10 Flos Farfaraees 7～15.
The optimum weight of the component of medicine of the present invention (part) proportioning is:
Herba Ephedrae (processed) 7 Pheretimas 18 Semen Armeniacae Amarums 10 Herba Houttuyniae 15 Radix Platycodoniss 10
Fructus Xanthii 5 Pulvis concha Mactrae 10 Radix Glycyrrhizaes 9 Flos Magnoliae 8 Flos Farfaraees 8.
Medicine of the present invention production technology is routinely made said various dosage forms on the pharmaceutics, as solution, unguentum, tablet, granule or capsule etc.
First important feature of medicine of the present invention is that clinical efficacy is definite and remarkable.Sum up and to be confirmed according to out-patient treatment 245 routine expectorant heat stagnation pneumonopathy people's curative effect.Utilize 245 examples of medicine out-patient treatment of the present invention, tcm diagnosis is the patient of expectorant heat stagnation lung, and with the diagnosis grouping of doctor trained in Western medicine, it is as follows that curative effect is respectively organized in summary:
Table 1 patient ordinary circumstance
| Total routine number | Man's (example) | Woman's (example) | Mean age |
| 245 | 142 | 103 | 52 |
| (the range of age 4-78 year) |
The curative effect of table 2 medicine of the present invention
| Cause of disease grouping | The example number | Clinic control | Produce effects | Take a turn for the better | Invalid | Total effective rate (%) |
| The COPD concurrent infection props up and expands the acute attack of concurrent infection pulmonary infection bronchial asthma bronchitis | 87 24 13 108 13 | 64 11 7 72 13 | 20 10 4 33 0 | 2 2 1 2 0 | 1 1 1 1 0 | 96.55 87.5 84.62 97.22 100 |
More than 5 groups of patient total effective rates be 95.51% clinic control+produce effects=effectively take a turn for the better+invalid=invalid
Second important feature of medicine of the present invention is to have tangible pleasant antiasthmatic effect.In clinical research and the test of having done relevant this respect: during patient's asthma attack, measure FEV with simple and easy peak expiratory flow rate instrument
1, take medicine of the present invention immediately, survey FEV after 30 minutes again
1
50 routine outpatient service prescription on individual diagnosis patient test results following (severe asthma and do not test below 12 years old):
| Before the treatment | After the treatment | |
| 50 case FEV 1Meansigma methods (liter/second) | 1.94 | 2.86 |
| Front and back contrast P value | P＜0.01 | |
The 3rd important holding a little of medicine of the present invention: the pleasant medicine of relievining asthma clinically usually, antitussive, apophlegmatisant are obviously to separate, and we can say that they are respectively to execute its duty, but medicine of the present invention selects medicine and prescription by the Chinese and western medicine theory combination.The inventor is from the upright solution of inscribing, repeatedly practise clinical to finishing prescription, just always pleasantly relieving asthma, the merit collection of cough-relieving expectoration, the detoxifcation of antiinflammatory antiallergic is that one is studied, allow medicine of the present invention contain effectively chemical analysis such as spasmolytic, antiinflammatory antiallergic, cough-relieving, antibiotic, antiinflammatory, detoxifcation expectoration, that these effective chemical analysis and medicine of the present invention show in clinical use is rapid-action, determined curative effect significantly, use effect such as wide that direct relation is arranged.
The 4th important feature of medicine of the present invention is: this drug prescription is reused clearing the nasal passage, is controlled the medicine of nose disease, not only meet of the physiopathologic argumentation of traditional traditional Chinese medical science about lungs such as lung opening at nose, nose, and mutual those neighbours of the upper and lower respiratory tract that meets the modern medicine proposition, organizational structure is identical, and each position disease is implicative of each other, interact and be referred to as the latest notion of ' systemic respiratory mucosa disease ' (systemic respiratory mucosal disease).Final report according to WHO one action in 2002 meeting shows simultaneously, has the patient of sniffle to surpass 80% more than in the asthma patient.So reuse clearing the nasal passage in the prescription of breathing heavily, coughing in treatment, control the medicine of nose disease, make nose, lung rule together up and down, unimpeded and to reach breathing freely suitable simultaneously, breathe heavily flat coughing and end.This be in, the doctor trained in Western medicine theory organically in conjunction with and be applied to clinical new results.
Clinical drug of the present invention shows the result, has following advantage:
1, curative effect of medication of the present invention is significantly definite, pleasantly relievings asthma rapid-actionly, and relieving cough and resolving phlegm, anti inflammatory detoxication are effective, and good clearing the nasal passage effect is arranged, and do not find that medicine has adverse side effect and toxicity to biological organs.
2, the raw material of choice of drug of the present invention is classical Chinese medicine, and each component meets the pharmaceutical control law regulation.Utilize the comprehensive do treatment of the medicine of respectively distinguishing the flavor of to breathe heavily, cough, expectorant, adding preservative agent is not nontoxic to human body.
3, medicine of the present invention be in, the theoretical scientific achievement that organically combines of doctor trained in Western medicine, a kind of medicine multiple efficacies can reduce types of medicines, save medical expense.
4, medicine of the present invention can be made various dosage forms with habitual common process, and is easy to use, both can use separately also and can unite use with other Chinese medicine and western medicine, when uniting use with Western medicine, can reduce the consumption of Western medicine and shorten treatment time.
The specific embodiment
Embodiment 1
The medicine that the present invention treats tachypnea, cough with asthma, coughs up phlegm, make its raw materials of effective components and consist of (consumption is a weight portion):
Herba Ephedrae (processed) 6 Pheretimas 9 Semen Armeniacae Amarums 2 Herba Houttuyniae 7 Radix Platycodoniss 5
Fructus Xanthii 3 Pulvis concha Mactrae 8 Radix Glycyrrhizaes 1 Flos Magnoliae 4 Flos Farfaraees 4
Embodiment 2
The medicine that the present invention treats tachypnea, cough with asthma, coughs up phlegm, make its raw materials of effective components and consist of (consumption is a weight portion):
Herba Ephedrae (processed) 8 Pheretimas 10 Semen Armeniacae Amarums 6 Herba Houttuyniae 9 Radix Platycodoniss 7
Fructus Xanthii 5 Pulvis concha Mactrae 12 Radix Glycyrrhizaes 1 Flos Magnoliae 6 Flos Farfaraees 7
Embodiment 3
The medicine that the present invention treats tachypnea, cough with asthma, coughs up phlegm, make its raw materials of effective components and consist of (consumption is a weight portion):
Herba Ephedrae (processed) 7 Pheretimas 12 Semen Armeniacae Amarums 8 Herba Houttuyniae 15 Radix Platycodoniss 10
Fructus Xanthii 8 Pulvis concha Mactrae 10 Radix Glycyrrhizaes 9 Flos Magnoliae 10 Flos Farfaraees 13
Embodiment 4
The medicine that the present invention treats tachypnea, cough with asthma, coughs up phlegm, make its raw materials of effective components and consist of (consumption is a weight portion):
Herba Ephedrae (processed) 10 Pheretimas 20 Semen Armeniacae Amarums 7 Herba Houttuyniae 15 Radix Platycodoniss 13
Fructus Xanthii 9 Pulvis concha Mactrae 6 Radix Glycyrrhizaes 15 Flos Magnoliae 12 Flos Farfaraees 10
Embodiment 5
The medicine that the present invention treats tachypnea, cough with asthma, coughs up phlegm, make its raw materials of effective components and consist of (consumption is a weight portion):
Herba Ephedrae (processed) 7 Pheretimas 18 Semen Armeniacae Amarums 10 Herba Houttuyniae 15 Radix Platycodoniss 10
Fructus Xanthii 5 Pulvis concha Mactrae 10 Radix Glycyrrhizaes 9 Flos Magnoliae 8 Flos Farfaraees 8
The above embodiment production technology routinely makes said various dosage forms on the pharmaceutics, as solution, unguentum, tablet, granule or capsule etc.
Claims (3)
1, a kind of medicine for the treatment of tachypnea, cough with asthma, coughing up phlegm is characterized in that making raw materials of effective components and consists of:
Herba Ephedrae (processed) 4～8 Pheretimas 10～24 Semen Armeniacae Amarums 6～10 Herba Houttuyniae 6～20 Radix Platycodoniss 10～15
Fructus Xanthii 4～8 Pulvis concha Mactrae 8～15 Radix Glycyrrhizaes 2～10 Flos Magnoliae 5～10 Flos Farfaraees 7～15
Wherein, the consumption of each raw material is the weight portion proportioning.
2, treatment tachypnea according to claim 1, cough with asthma, the medicine of coughing up phlegm, wherein the weight portion proportioning of each raw material is:
Herba Ephedrae (processed) 7 Pheretimas 18 Semen Armeniacae Amarums 10 Herba Houttuyniae 15 Radix Platycodoniss 10
Fructus Xanthii 5 Pulvis concha Mactrae 10 Radix Glycyrrhizaes 9 Flos Magnoliae 8 Flos Farfaraees 8.
3, treatment tachypnea according to claim 1 and 2, cough with asthma, the medicine of coughing up phlegm, the dosage form that it is characterized in that medicine is solution, unguentum, tablet, granule or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100349969A CN1301120C (en) | 2005-06-03 | 2005-06-03 | Medicine for treating breadth gasp, cough, asthma and phelgm |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100349969A CN1301120C (en) | 2005-06-03 | 2005-06-03 | Medicine for treating breadth gasp, cough, asthma and phelgm |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1720936A CN1720936A (en) | 2006-01-18 |
| CN1301120C true CN1301120C (en) | 2007-02-21 |
Family
ID=35911772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100349969A Active CN1301120C (en) | 2005-06-03 | 2005-06-03 | Medicine for treating breadth gasp, cough, asthma and phelgm |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1301120C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104721766B (en) * | 2013-12-19 | 2019-04-02 | 上海市嘉定区中医医院 | The Chinese medicine composition and its preparation method and application for treating cough and asthma |
| CN104069227A (en) * | 2014-07-23 | 2014-10-01 | 河南中医学院 | Traditional Chinese medicine for treating coughing, phlegm, and asthma |
| CN105327138A (en) * | 2015-10-24 | 2016-02-17 | 张国显 | Weasand recovering pill |
| CN106039056A (en) * | 2016-06-24 | 2016-10-26 | 王立丽 | Medicine composition for treating infantile cough and asthma |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114891A (en) * | 1994-07-11 | 1996-01-17 | 丛繁滋 | "Yinhuang" inhalation, spray agent (snuff bottle), enema liquid and its preparation method |
| CN1307881A (en) * | 2000-12-27 | 2001-08-15 | 林定增 | Medicine for treating cough and asthma |
-
2005
- 2005-06-03 CN CNB2005100349969A patent/CN1301120C/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1114891A (en) * | 1994-07-11 | 1996-01-17 | 丛繁滋 | "Yinhuang" inhalation, spray agent (snuff bottle), enema liquid and its preparation method |
| CN1307881A (en) * | 2000-12-27 | 2001-08-15 | 林定增 | Medicine for treating cough and asthma |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1720936A (en) | 2006-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1301120C (en) | Medicine for treating breadth gasp, cough, asthma and phelgm | |
| CN1965900A (en) | Externally applied Chinese medicinal composition for treating nasal sinuitis | |
| CN1679864A (en) | Chinese medicine preparation for treating bronchitis | |
| CN1201793C (en) | Medicine composition for treatment of cough and asthma and preparation thereof | |
| CN1343513A (en) | Chinese medicine for treating rhinitis and nasosinusitis | |
| CN1742912A (en) | Medicine for treating and preventing chronic obstractive pneumonia | |
| CN104225404A (en) | Pharmaceutical composition for treating pulmonary fibrosis and preparation of pharmaceutical composition | |
| CN1294930C (en) | Medication for treating cough caused by inflammation of upper respiratory tract | |
| CN102000292B (en) | Traditional Chinese medical preparation for treating bronchitis | |
| CN1254254C (en) | Chinese patent drug for treating nasosinusitis | |
| CN1846781A (en) | Medicine for treating chronic pharyngitis | |
| CN102641350B (en) | Lung-warming panting-calming granule and preparation process thereof | |
| CN1305521C (en) | Cold treating medicine | |
| CN102772525A (en) | Traditional Chinese medicine for wind-heat type acute bronchitis | |
| CN1290570C (en) | Medical liquor for treating bronchial asthma and drug administering apparatus thereof | |
| CN1131062C (en) | Trachitis treating Chinese medicine | |
| CN1593587A (en) | Lung nourishing and regulating pill for treating lung system diseases and preparation method thereof | |
| CN101450187A (en) | Medicine composition for treating asthma | |
| CN1111051C (en) | Medicine for treating cough and asthma | |
| CN1775282A (en) | Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method | |
| CN104208372A (en) | Traditional Chinese medicine formula treating bronchial asthma | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN102641412B (en) | Root-securing and panting-calming granule and preparation process thereof | |
| CN1281257C (en) | Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis | |
| CN1876075A (en) | A medicine for treating asthma, acute and chronic bronchitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: YU JIA Free format text: FORMER OWNER: LIN DINGZENG Effective date: 20120919 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510180 GUANGZHOU, GUANGDONG PROVINCE TO: 510623 GUANGZHOU, GUANGDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120919 Address after: 510623 Guangdong Province, Guangzhou Tianhe District Zhujiang New City, Golden Harvest Road No. 721 Sea View Park A-1202 Patentee after: Yu Jia Address before: 510180, dormitory 1207, 28 dormitory, Guangzhou Medical College, 195 Dongfeng West Road, Guangdong, Guangzhou Patentee before: Lin Dingzeng |